Nisa Investment Advisors LLC raised its position in Quanterix Co. (NASDAQ:QTRX) by 36.0% during the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 1,700 shares of the company’s stock after purchasing an additional 450 shares during the period. Nisa Investment Advisors LLC’s holdings in Quanterix were worth $100,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently bought and sold shares of the business. PNC Financial Services Group Inc. boosted its stake in Quanterix by 49.3% in the 2nd quarter. PNC Financial Services Group Inc. now owns 1,587 shares of the company’s stock worth $93,000 after buying an additional 524 shares during the last quarter. Valmark Advisers Inc. raised its holdings in shares of Quanterix by 3.3% during the 2nd quarter. Valmark Advisers Inc. now owns 54,374 shares of the company’s stock valued at $3,190,000 after buying an additional 1,725 shares during the period. Rhumbline Advisers raised its holdings in shares of Quanterix by 22.2% during the 2nd quarter. Rhumbline Advisers now owns 31,472 shares of the company’s stock valued at $1,846,000 after buying an additional 5,709 shares during the period. US Bancorp DE increased its holdings in Quanterix by 103.1% during the 2nd quarter. US Bancorp DE now owns 1,489 shares of the company’s stock worth $87,000 after purchasing an additional 756 shares during the last quarter. Finally, Envestnet Asset Management Inc. purchased a new stake in Quanterix during the 2nd quarter worth approximately $600,000. 82.12% of the stock is currently owned by institutional investors.
In other news, SVP David C. Duffy sold 1,667 shares of the firm’s stock in a transaction dated Wednesday, July 14th. The stock was sold at an average price of $57.77, for a total value of $96,302.59. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO E Kevin Hrusovsky sold 3,648 shares of Quanterix stock in a transaction dated Tuesday, August 3rd. The stock was sold at an average price of $53.79, for a total value of $196,225.92. The disclosure for this sale can be found here. Insiders have sold a total of 17,817 shares of company stock worth $998,631 in the last ninety days. 15.40% of the stock is currently owned by company insiders.
Shares of QTRX opened at $50.27 on Friday. Quanterix Co. has a 1 year low of $31.24 and a 1 year high of $92.57. The stock has a 50 day simple moving average of $51.00 and a 200-day simple moving average of $55.89. The stock has a market cap of $1.84 billion, a PE ratio of -58.45 and a beta of 1.52.
Quanterix (NASDAQ:QTRX) last released its quarterly earnings results on Thursday, August 5th. The company reported ($0.33) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.32) by ($0.01). The business had revenue of $25.37 million for the quarter, compared to the consensus estimate of $23.59 million. Quanterix had a negative return on equity of 8.76% and a negative net margin of 26.90%. As a group, analysts anticipate that Quanterix Co. will post -1.23 earnings per share for the current fiscal year.
Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development.
See Also: What is the yield curve?
Want to see what other hedge funds are holding QTRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quanterix Co. (NASDAQ:QTRX).
Receive News & Ratings for Quanterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quanterix and related companies with MarketBeat.com's FREE daily email newsletter.